BIZZARI JEAN-PIERRE 4
4 · HALOZYME THERAPEUTICS, INC. · Filed May 1, 2020
Insider Transaction Report
Form 4
BIZZARI JEAN-PIERRE
Director
Transactions
- Award
Common Stock
2020-04-30+8,829→ 82,314 total
Footnotes (1)
- [F1]Represents annual restricted stock grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) April 30, 2021 and (ii) the date of the Issuer's next annual meeting of stockholders.